These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 26633297)

  • 1. Genetic Deletion of the Stromal Cell Marker CD248 (Endosialin) Protects against the Development of Renal Fibrosis.
    Smith SW; Croft AP; Morris HL; Naylor AJ; Huso DL; Isacke CM; Savage CO; Buckley CD
    Nephron; 2015; 131(4):265-77. PubMed ID: 26633297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting fibroblast CD248 attenuates CCL17-expressing macrophages and tissue fibrosis.
    Pai CH; Lin SR; Liu CH; Pan SY; Hsu H; Chen YT; Yen CT; Yu IS; Wu HL; Lin SL; Lin SW
    Sci Rep; 2020 Oct; 10(1):16772. PubMed ID: 33033277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD248+ stromal cells are associated with progressive chronic kidney disease.
    Smith SW; Eardley KS; Croft AP; Nwosu J; Howie AJ; Cockwell P; Isacke CM; Buckley CD; Savage CO
    Kidney Int; 2011 Jul; 80(2):199-207. PubMed ID: 21490589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autophagy in FOXD1 stroma-derived cells regulates renal fibrosis through TGF-β and NLRP3 inflammasome pathway.
    Nam SA; Kim WY; Kim JW; Kang MG; Park SH; Lee MS; Kim HW; Yang CW; Kim J; Kim YK
    Biochem Biophys Res Commun; 2019 Jan; 508(3):965-972. PubMed ID: 30545632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet-derived growth factor receptor signaling activates pericyte-myofibroblast transition in obstructive and post-ischemic kidney fibrosis.
    Chen YT; Chang FC; Wu CF; Chou YH; Hsu HL; Chiang WC; Shen J; Chen YM; Wu KD; Tsai TJ; Duffield JS; Lin SL
    Kidney Int; 2011 Dec; 80(11):1170-81. PubMed ID: 21716259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kidney pericytes: a novel therapeutic target in interstitial fibrosis.
    Smith SW; Schrimpf C; Parekh DJ; Venkatachalam M; Duffield JS
    Histol Histopathol; 2012 Dec; 27(12):1503-14. PubMed ID: 23059881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pericyte and stromal cell marker CD248 (endosialin) is required for efficient lymph node expansion.
    Lax S; Hardie DL; Wilson A; Douglas MR; Anderson G; Huso D; Isacke CM; Buckley CD
    Eur J Immunol; 2010 Jul; 40(7):1884-9. PubMed ID: 20432232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Putative endothelial progenitor cells do not promote vascular repair but attenuate pericyte-myofibroblast transition in UUO-induced renal fibrosis.
    Yang J; Wang M; Zhu F; Sun J; Xu H; Chong Lee Shin OL; Zhao Z; Pei G; Zhu H; Cao C; He X; Huang Y; Ma Z; Liu L; Wang L; Ning Y; Liu W; Xu G; Wang X; Zeng R; Yao Y
    Stem Cell Res Ther; 2019 Mar; 10(1):104. PubMed ID: 30898157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blocking CD248 molecules in perivascular stromal cells of patients with systemic sclerosis strongly inhibits their differentiation toward myofibroblasts and proliferation: a new potential target for antifibrotic therapy.
    Di Benedetto P; Liakouli V; Ruscitti P; Berardicurti O; Carubbi F; Panzera N; Di Bartolomeo S; Guggino G; Ciccia F; Triolo G; Cipriani P; Giacomelli R
    Arthritis Res Ther; 2018 Oct; 20(1):223. PubMed ID: 30285896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of fibrosis: the role of the pericyte.
    Schrimpf C; Duffield JS
    Curr Opin Nephrol Hypertens; 2011 May; 20(3):297-305. PubMed ID: 21422927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of CD248 as a potential severity marker in idiopathic pulmonary fibrosis.
    Bartis D; Crowley LE; D'Souza VK; Borthwick L; Fisher AJ; Croft AP; Pongrácz JE; Thompson R; Langman G; Buckley CD; Thickett DR
    BMC Pulm Med; 2016 Apr; 16(1):51. PubMed ID: 27080864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The stromal cell antigen CD248 (endosialin) is expressed on naive CD8+ human T cells and regulates proliferation.
    Hardie DL; Baldwin MJ; Naylor A; Haworth OJ; Hou TZ; Lax S; Curnow SJ; Willcox N; MacFadyen J; Isacke CM; Buckley CD
    Immunology; 2011 Jul; 133(3):288-95. PubMed ID: 21466550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody-drug conjugates targeting CD248
    Xu C; Liu S; Yang F; Zhang K; Li Y; Zhao X; Zhang J; Lu T; Lu S; Jiang Y; Qin W; Shi C; Zhang R; Yang AG; Zhao A; Han D; Wen W
    FASEB J; 2022 Feb; 36(2):e22102. PubMed ID: 34972243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel insights into pericyte-myofibroblast transition and therapeutic targets in renal fibrosis.
    Chang FC; Chou YH; Chen YT; Lin SL
    J Formos Med Assoc; 2012 Nov; 111(11):589-98. PubMed ID: 23217594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endosialin/TEM 1/CD248 is a pericyte marker of embryonic and tumor neovascularization.
    Bagley RG; Honma N; Weber W; Boutin P; Rouleau C; Shankara S; Kataoka S; Ishida I; Roberts BL; Teicher BA
    Microvasc Res; 2008 Nov; 76(3):180-8. PubMed ID: 18761022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting endosialin/CD248 through antibody-mediated internalization results in impaired pericyte maturation and dysfunctional tumor microvasculature.
    Rybinski K; Imtiyaz HZ; Mittica B; Drozdowski B; Fulmer J; Furuuchi K; Fernando S; Henry M; Chao Q; Kline B; Albone E; Wustner J; Lin J; Nicolaides NC; Grasso L; Zhou Y
    Oncotarget; 2015 Sep; 6(28):25429-40. PubMed ID: 26327620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterozygous disruption of activin receptor-like kinase 1 is associated with increased renal fibrosis in a mouse model of obstructive nephropathy.
    Muñoz-Félix JM; López-Novoa JM; Martínez-Salgado C
    Kidney Int; 2014 Feb; 85(2):319-32. PubMed ID: 23945497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Signaling mechanism of renal fibrosis in unilateral ureteral obstructive kidney disease in ROCK1 knockout mice.
    Fu P; Liu F; Su S; Wang W; Huang XR; Entman ML; Schwartz RJ; Wei L; Lan HY
    J Am Soc Nephrol; 2006 Nov; 17(11):3105-14. PubMed ID: 17005937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of lysyl oxidase ameliorates renal injury by inhibiting CD44-mediated pericyte detachment and loss of peritubular capillaries.
    Saifi MA; Godugu C
    Life Sci; 2020 Feb; 243():117294. PubMed ID: 31927047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD248 and its cytoplasmic domain: a therapeutic target for arthritis.
    Maia M; de Vriese A; Janssens T; Moons M; van Landuyt K; Tavernier J; Lories RJ; Conway EM
    Arthritis Rheum; 2010 Dec; 62(12):3595-606. PubMed ID: 20722022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.